Accelerating the new wave of CAR T therapy trials

Sponsored content By Worldwide Clinical Trials

CAR T-cell therapy, which has revolutionized the treatment of B-cell lineage hematological malignancies, is now being applied in new ways to solid tumors and various autoimmune diseases. This exciting evolution brings new hope and unique challenges. Worldwide Clinical Trials is at the forefront, partnering with drug development teams to map this new path forward.

While these advancements are promising, applying CAR T-cell therapy in new clinical settings presents unique challenges. For example, treating conditions like Multiple Sclerosis or Myasthenia Gravis in Neurology clinics or Systemic Lupus Erythematosus and Rheumatoid Arthritis in Rheumatology clinics requires collaboration between specialist clinics and established Oncology cell therapy infrastructure. These trials are inherently more complex, increasing stakeholder needs...

Today's Sponsors

Today's Sponsor